Erythropoietin attenuated high glucose-induced apoptosis in cultured human aortic endothelial cells

Naotaka Sekiguchi, Toyoshi Inoguchi, Kunihisa Kobayashi, Noriyuki Sonoda, Hajime Nawata

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

High glucose-induced apoptosis in vascular endothelial cells may contribute to the acceleration of atherosclerosis associated with diabetes. Here, we show that erythropoietin attenuates high glucose-induced apoptosis in cultured human aortic endothelial cells (HAECs). Exposure of HAECs to high glucose level for 72 h significantly increased the number of apoptotic cells compared with normal glucose level, as evaluated by TUNEL assay. Simultaneous addition of erythropoietin (100 U/ml) significantly attenuated high glucose-induced apoptosis. In parallel, exposure to high glucose level induced caspase-3 activation and erythropoietin also prevented it. Erythropoietin stimulated Akt phosphorylation in a dose-dependent manner (1-100 U/ml). PI3 kinase inhibitor, wortmannin or LY294002 eliminated erythropoietin's inhibitory effect on caspase-3 activity. In conclusion, erythropoietin may attenuate high glucose-induced endothelial cell apoptosis via PI-3 kinase pathway. Replacing therapy with erythropoietin is often used for correction of renal anemia, but may have potential in preventing atherosclerosis in diabetic patients with end-stage renal failure.

Original languageEnglish
Pages (from-to)218-222
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume334
Issue number1
DOIs
Publication statusPublished - Aug 19 2005

Fingerprint

Endothelial cells
Erythropoietin
Endothelial Cells
Apoptosis
Glucose
Phosphatidylinositol 3-Kinases
Caspase 3
Atherosclerosis
Phosphorylation
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
In Situ Nick-End Labeling
Medical problems
Chronic Kidney Failure
Anemia
Assays
Cell Count
Chemical activation
Cells
Kidney

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Erythropoietin attenuated high glucose-induced apoptosis in cultured human aortic endothelial cells. / Sekiguchi, Naotaka; Inoguchi, Toyoshi; Kobayashi, Kunihisa; Sonoda, Noriyuki; Nawata, Hajime.

In: Biochemical and Biophysical Research Communications, Vol. 334, No. 1, 19.08.2005, p. 218-222.

Research output: Contribution to journalArticle

Sekiguchi, Naotaka ; Inoguchi, Toyoshi ; Kobayashi, Kunihisa ; Sonoda, Noriyuki ; Nawata, Hajime. / Erythropoietin attenuated high glucose-induced apoptosis in cultured human aortic endothelial cells. In: Biochemical and Biophysical Research Communications. 2005 ; Vol. 334, No. 1. pp. 218-222.
@article{c04c723566c5414cb12f9ff5958a9b82,
title = "Erythropoietin attenuated high glucose-induced apoptosis in cultured human aortic endothelial cells",
abstract = "High glucose-induced apoptosis in vascular endothelial cells may contribute to the acceleration of atherosclerosis associated with diabetes. Here, we show that erythropoietin attenuates high glucose-induced apoptosis in cultured human aortic endothelial cells (HAECs). Exposure of HAECs to high glucose level for 72 h significantly increased the number of apoptotic cells compared with normal glucose level, as evaluated by TUNEL assay. Simultaneous addition of erythropoietin (100 U/ml) significantly attenuated high glucose-induced apoptosis. In parallel, exposure to high glucose level induced caspase-3 activation and erythropoietin also prevented it. Erythropoietin stimulated Akt phosphorylation in a dose-dependent manner (1-100 U/ml). PI3 kinase inhibitor, wortmannin or LY294002 eliminated erythropoietin's inhibitory effect on caspase-3 activity. In conclusion, erythropoietin may attenuate high glucose-induced endothelial cell apoptosis via PI-3 kinase pathway. Replacing therapy with erythropoietin is often used for correction of renal anemia, but may have potential in preventing atherosclerosis in diabetic patients with end-stage renal failure.",
author = "Naotaka Sekiguchi and Toyoshi Inoguchi and Kunihisa Kobayashi and Noriyuki Sonoda and Hajime Nawata",
year = "2005",
month = "8",
day = "19",
doi = "10.1016/j.bbrc.2005.06.072",
language = "English",
volume = "334",
pages = "218--222",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Erythropoietin attenuated high glucose-induced apoptosis in cultured human aortic endothelial cells

AU - Sekiguchi, Naotaka

AU - Inoguchi, Toyoshi

AU - Kobayashi, Kunihisa

AU - Sonoda, Noriyuki

AU - Nawata, Hajime

PY - 2005/8/19

Y1 - 2005/8/19

N2 - High glucose-induced apoptosis in vascular endothelial cells may contribute to the acceleration of atherosclerosis associated with diabetes. Here, we show that erythropoietin attenuates high glucose-induced apoptosis in cultured human aortic endothelial cells (HAECs). Exposure of HAECs to high glucose level for 72 h significantly increased the number of apoptotic cells compared with normal glucose level, as evaluated by TUNEL assay. Simultaneous addition of erythropoietin (100 U/ml) significantly attenuated high glucose-induced apoptosis. In parallel, exposure to high glucose level induced caspase-3 activation and erythropoietin also prevented it. Erythropoietin stimulated Akt phosphorylation in a dose-dependent manner (1-100 U/ml). PI3 kinase inhibitor, wortmannin or LY294002 eliminated erythropoietin's inhibitory effect on caspase-3 activity. In conclusion, erythropoietin may attenuate high glucose-induced endothelial cell apoptosis via PI-3 kinase pathway. Replacing therapy with erythropoietin is often used for correction of renal anemia, but may have potential in preventing atherosclerosis in diabetic patients with end-stage renal failure.

AB - High glucose-induced apoptosis in vascular endothelial cells may contribute to the acceleration of atherosclerosis associated with diabetes. Here, we show that erythropoietin attenuates high glucose-induced apoptosis in cultured human aortic endothelial cells (HAECs). Exposure of HAECs to high glucose level for 72 h significantly increased the number of apoptotic cells compared with normal glucose level, as evaluated by TUNEL assay. Simultaneous addition of erythropoietin (100 U/ml) significantly attenuated high glucose-induced apoptosis. In parallel, exposure to high glucose level induced caspase-3 activation and erythropoietin also prevented it. Erythropoietin stimulated Akt phosphorylation in a dose-dependent manner (1-100 U/ml). PI3 kinase inhibitor, wortmannin or LY294002 eliminated erythropoietin's inhibitory effect on caspase-3 activity. In conclusion, erythropoietin may attenuate high glucose-induced endothelial cell apoptosis via PI-3 kinase pathway. Replacing therapy with erythropoietin is often used for correction of renal anemia, but may have potential in preventing atherosclerosis in diabetic patients with end-stage renal failure.

UR - http://www.scopus.com/inward/record.url?scp=22144458380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22144458380&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2005.06.072

DO - 10.1016/j.bbrc.2005.06.072

M3 - Article

C2 - 15993382

AN - SCOPUS:22144458380

VL - 334

SP - 218

EP - 222

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -